Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112665516 | 11266551 | 6 | F | 20130325 | 20160809 | 20150713 | 20160811 | EXP | PHHY2013CA030066 | NOVARTIS | 67.62 | YR | M | Y | 0.00000 | 20160811 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112665516 | 11266551 | 1 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS) | U | 0 | 30 | MG | /month | ||||||
| 112665516 | 11266551 | 2 | PS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | 50 UG, ONCE/SINGLE (TEST DOSE) | 50 | UG | 19667 | 50 | UG | 1X | |||||
| 112665516 | 11266551 | 3 | SS | METOPROLOL. | METOPROLOL | 1 | Unknown | 25 MG, BID | U | 0 | 25 | MG | BID | ||||||
| 112665516 | 11266551 | 4 | C | NITRO PATCH | NITROGLYCERIN | 1 | Unknown | 0.4 MG/H, UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112665516 | 11266551 | 1 | Neuroendocrine tumour |
| 112665516 | 11266551 | 2 | Neuroendocrine tumour |
| 112665516 | 11266551 | 3 | Chest pain |
| 112665516 | 11266551 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112665516 | 11266551 | HO |
| 112665516 | 11266551 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112665516 | 11266551 | Abdominal pain | |
| 112665516 | 11266551 | Abnormal faeces | |
| 112665516 | 11266551 | Blood pressure diastolic decreased | |
| 112665516 | 11266551 | Blood pressure increased | |
| 112665516 | 11266551 | Blood pressure systolic increased | |
| 112665516 | 11266551 | Chest pain | |
| 112665516 | 11266551 | Diarrhoea | |
| 112665516 | 11266551 | Flatulence | |
| 112665516 | 11266551 | Gastrointestinal disorder | |
| 112665516 | 11266551 | Gout | |
| 112665516 | 11266551 | Injection site pain | |
| 112665516 | 11266551 | Myocardial infarction | |
| 112665516 | 11266551 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112665516 | 11266551 | 1 | 20130307 | 0 | ||
| 112665516 | 11266551 | 2 | 20130307 | 20130307 | 0 |